Cargando…

Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice

SIMPLE SUMMARY: HER2, which is associated with clinically aggressive disease, is overexpressed in 15–20% of breast cancers (BC). Peroxisome proliferator-activated receptor γ (PPARγ), is expressed in a variety of malignancies. The aim of our study was to determine the function of endogenous Pparγ1 in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Xuanmao, Tian, Lifeng, Zhang, Zhao, Balcerek, Joanna, Kossenkov, Andrew V., Casimiro, Mathew C., Wang, Chenguang, Liu, Yichuan, Ertel, Adam, Soccio, Raymond E., Chen, Eric R., Liu, Qin, Ashton, Anthony W., Tong, Wei, Pestell, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125290/
https://www.ncbi.nlm.nih.gov/pubmed/33946495
http://dx.doi.org/10.3390/cancers13092171
_version_ 1783693457931370496
author Jiao, Xuanmao
Tian, Lifeng
Zhang, Zhao
Balcerek, Joanna
Kossenkov, Andrew V.
Casimiro, Mathew C.
Wang, Chenguang
Liu, Yichuan
Ertel, Adam
Soccio, Raymond E.
Chen, Eric R.
Liu, Qin
Ashton, Anthony W.
Tong, Wei
Pestell, Richard G.
author_facet Jiao, Xuanmao
Tian, Lifeng
Zhang, Zhao
Balcerek, Joanna
Kossenkov, Andrew V.
Casimiro, Mathew C.
Wang, Chenguang
Liu, Yichuan
Ertel, Adam
Soccio, Raymond E.
Chen, Eric R.
Liu, Qin
Ashton, Anthony W.
Tong, Wei
Pestell, Richard G.
author_sort Jiao, Xuanmao
collection PubMed
description SIMPLE SUMMARY: HER2, which is associated with clinically aggressive disease, is overexpressed in 15–20% of breast cancers (BC). Peroxisome proliferator-activated receptor γ (PPARγ), is expressed in a variety of malignancies. The aim of our study was to determine the function of endogenous Pparγ1 in the onset and progression of mammary tumors induced by ErbB2 in mice. Genetic deletion of Pparγ1 slowed the rate of tumor progression and death from ErbB2-induced mammary tumors. The deletion of Pparγ1 correlated with reduced pro-tumorigenic inflammation. We conclude ErbB2 collaborates with endogenous Pparγ1 in the onset and progression of mammary tumorigenesis. ABSTRACT: HER2, which is associated with clinically aggressive disease, is overexpressed in 15–20% of breast cancers (BC). The host immune system participates in the therapeutic response of HER2(+) breast cancer. Identifying genetic programs that participate in ErbB2-induced tumors may provide the rational basis for co-extinction therapeutic approaches. Peroxisome proliferator-activated receptor γ (PPARγ), which is expressed in a variety of malignancies, governs biological functions through transcriptional programs. Herein, genetic deletion of endogenous Pparγ1 restrained mammary tumor progression, lipogenesis, and induced local mammary tumor macrophage infiltration, without affecting other tissue hematopoietic stem cell pools. Endogenous Pparγ1 induced expression of both an EphA2-Amphiregulin and an inflammatory INFγ and Cxcl5 signaling module, that was recapitulated in human breast cancer. Pparγ1 bound directly to growth promoting and proinflammatory target genes in the context of chromatin. We conclude Pparγ1 promotes ErbB2-induced tumor growth and inflammation and represents a relevant target for therapeutic coextinction. Herein, endogenous Pparγ1 promoted ErbB2-mediated mammary tumor onset and progression. PPARγ1 increased expression of an EGF-EphA2 receptor tyrosine kinase module and a cytokine/chemokine 1 transcriptional module. The induction of a pro-tumorigenic inflammatory state by Pparγ1 may provide the rationale for complementary coextinction programs in ErbB2 tumors.
format Online
Article
Text
id pubmed-8125290
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81252902021-05-17 Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice Jiao, Xuanmao Tian, Lifeng Zhang, Zhao Balcerek, Joanna Kossenkov, Andrew V. Casimiro, Mathew C. Wang, Chenguang Liu, Yichuan Ertel, Adam Soccio, Raymond E. Chen, Eric R. Liu, Qin Ashton, Anthony W. Tong, Wei Pestell, Richard G. Cancers (Basel) Article SIMPLE SUMMARY: HER2, which is associated with clinically aggressive disease, is overexpressed in 15–20% of breast cancers (BC). Peroxisome proliferator-activated receptor γ (PPARγ), is expressed in a variety of malignancies. The aim of our study was to determine the function of endogenous Pparγ1 in the onset and progression of mammary tumors induced by ErbB2 in mice. Genetic deletion of Pparγ1 slowed the rate of tumor progression and death from ErbB2-induced mammary tumors. The deletion of Pparγ1 correlated with reduced pro-tumorigenic inflammation. We conclude ErbB2 collaborates with endogenous Pparγ1 in the onset and progression of mammary tumorigenesis. ABSTRACT: HER2, which is associated with clinically aggressive disease, is overexpressed in 15–20% of breast cancers (BC). The host immune system participates in the therapeutic response of HER2(+) breast cancer. Identifying genetic programs that participate in ErbB2-induced tumors may provide the rational basis for co-extinction therapeutic approaches. Peroxisome proliferator-activated receptor γ (PPARγ), which is expressed in a variety of malignancies, governs biological functions through transcriptional programs. Herein, genetic deletion of endogenous Pparγ1 restrained mammary tumor progression, lipogenesis, and induced local mammary tumor macrophage infiltration, without affecting other tissue hematopoietic stem cell pools. Endogenous Pparγ1 induced expression of both an EphA2-Amphiregulin and an inflammatory INFγ and Cxcl5 signaling module, that was recapitulated in human breast cancer. Pparγ1 bound directly to growth promoting and proinflammatory target genes in the context of chromatin. We conclude Pparγ1 promotes ErbB2-induced tumor growth and inflammation and represents a relevant target for therapeutic coextinction. Herein, endogenous Pparγ1 promoted ErbB2-mediated mammary tumor onset and progression. PPARγ1 increased expression of an EGF-EphA2 receptor tyrosine kinase module and a cytokine/chemokine 1 transcriptional module. The induction of a pro-tumorigenic inflammatory state by Pparγ1 may provide the rationale for complementary coextinction programs in ErbB2 tumors. MDPI 2021-04-30 /pmc/articles/PMC8125290/ /pubmed/33946495 http://dx.doi.org/10.3390/cancers13092171 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jiao, Xuanmao
Tian, Lifeng
Zhang, Zhao
Balcerek, Joanna
Kossenkov, Andrew V.
Casimiro, Mathew C.
Wang, Chenguang
Liu, Yichuan
Ertel, Adam
Soccio, Raymond E.
Chen, Eric R.
Liu, Qin
Ashton, Anthony W.
Tong, Wei
Pestell, Richard G.
Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
title Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
title_full Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
title_fullStr Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
title_full_unstemmed Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
title_short Pparγ1 Facilitates ErbB2-Mammary Adenocarcinoma in Mice
title_sort pparγ1 facilitates erbb2-mammary adenocarcinoma in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8125290/
https://www.ncbi.nlm.nih.gov/pubmed/33946495
http://dx.doi.org/10.3390/cancers13092171
work_keys_str_mv AT jiaoxuanmao pparg1facilitateserbb2mammaryadenocarcinomainmice
AT tianlifeng pparg1facilitateserbb2mammaryadenocarcinomainmice
AT zhangzhao pparg1facilitateserbb2mammaryadenocarcinomainmice
AT balcerekjoanna pparg1facilitateserbb2mammaryadenocarcinomainmice
AT kossenkovandrewv pparg1facilitateserbb2mammaryadenocarcinomainmice
AT casimiromathewc pparg1facilitateserbb2mammaryadenocarcinomainmice
AT wangchenguang pparg1facilitateserbb2mammaryadenocarcinomainmice
AT liuyichuan pparg1facilitateserbb2mammaryadenocarcinomainmice
AT erteladam pparg1facilitateserbb2mammaryadenocarcinomainmice
AT soccioraymonde pparg1facilitateserbb2mammaryadenocarcinomainmice
AT chenericr pparg1facilitateserbb2mammaryadenocarcinomainmice
AT liuqin pparg1facilitateserbb2mammaryadenocarcinomainmice
AT ashtonanthonyw pparg1facilitateserbb2mammaryadenocarcinomainmice
AT tongwei pparg1facilitateserbb2mammaryadenocarcinomainmice
AT pestellrichardg pparg1facilitateserbb2mammaryadenocarcinomainmice